FDA warning letters documentation – Pharma GMP

Risk Assessment Guide for Illegible or Smudged Records

digi — Fri, 14 Nov 2025 10:42:28 +0000

Risk Assessment Guide for Illegible or Smudged Records Risk Assessment for Illegible or Smudged GMP Records Introduction: Why This Topic Matters for GMP Compliance Legibility of GMP records is more than a clerical requirement—it is a regulatory necessity. Records that are smudged, faded, or illegible undermine data integrity and can prevent regulators from verifying compliance...

Real-Life Warning Letters for Incomplete Manufacturing Records

digi — Sat, 13 Sep 2025 06:30:45 +0000

Real-Life Warning Letters for Incomplete Manufacturing Records Case Studies: FDA Warning Letters for Incomplete Manufacturing Records Introduction: Why This Topic Matters for GMP Compliance Manufacturing records form the backbone of Good Manufacturing Practice (GMP) compliance. They provide regulators with the evidence that every step of production, testing, and packaging was performed according to approved procedures....

How to Handle Missing Batch Records During a GMP Audit

digi — Wed, 10 Sep 2025 08:43:22 +0000

How to Handle Missing Batch Records During a GMP Audit Managing Missing Batch Records During GMP Audits Introduction: Why This Topic Matters for GMP Compliance Batch records are one of the most critical documents in pharmaceutical manufacturing. They serve as the evidence that every step in the production, packaging, and testing process was executed according...

Common GMP Documentation Failures Found in FDA 483s

digi — Wed, 10 Sep 2025 01:25:22 +0000

Common GMP Documentation Failures Found in FDA 483s Most Frequent GMP Documentation Failures in FDA 483s Introduction: Why This Topic Matters for GMP Compliance Documentation forms the backbone of Good Manufacturing Practice (GMP) compliance. Regulatory agencies, especially the U.S. Food and Drug Administration (FDA), repeatedly stress that if an activity is not documented, it is...